Model
Edge
EyePoint Pharmaceuticals Inc.
0002013623
Filing Type
144
Filing Date
11/11/2025
Updated
11/12/25, 4:55 AM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities